Drug Shortage Report for MYLAN-INDAPAMIDE
Report ID | 232575 |
Drug Identification Number | 02240067 |
Brand name | MYLAN-INDAPAMIDE |
Common or Proper name | INDAPAMIDE |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | INDAPAMIDE |
Strength(s) | 1.25MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100BT |
ATC code | C03BA |
ATC description | LOW-CEILING DIURETICS, EXCL THIAZIDES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2024-07-15 |
Actual start date | 2024-09-13 |
Estimated end date | 2024-10-22 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-10-08 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v19 | 2024-10-08 | French | Compare |
v18 | 2024-10-08 | English | Compare |
v17 | 2024-10-04 | French | Compare |
v16 | 2024-10-04 | English | Compare |
v15 | 2024-09-17 | French | Compare |
v14 | 2024-09-17 | English | Compare |
v13 | 2024-08-27 | French | Compare |
v12 | 2024-08-27 | English | Compare |
v11 | 2024-08-20 | French | Compare |
v10 | 2024-08-20 | English | Compare |
v9 | 2024-08-06 | French | Compare |
v8 | 2024-08-06 | English | Compare |
v7 | 2024-07-29 | French | Compare |
v6 | 2024-07-29 | English | Compare |
v5 | 2024-07-16 | French | Compare |
v4 | 2024-07-16 | English | Compare |
v3 | 2024-07-16 | English | Compare |
v2 | 2024-07-09 | French | Compare |
v1 | 2024-07-09 | English | Compare |
Showing 1 to 19 of 19